J&J (JNJ) Receives FDA Warning Letter Related to K-Y Vaginal Moisturizer -WSJ
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Join SI Premium – FREE
WSJ reporting J&J (NYSE: JNJ) has received an FDA warning letter related to its K-Y vaginal moisturizer.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
- CORVEX (MOVE) files $500M mixed shelf
- USA Rare Earth (USAR) files $1.25B mixed shelf
Create E-mail Alert Related Categories
Corporate News, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
